+ rIgG 1 13B8.2
1
+ rIgG 1 13B8.2 10 0 10 1 10 2 10 0 10 1 10 2 Anti-ceramide antibody Events 0 40 Non-permeabilized Jurkat T cells Permeabilize d Jurkat T cells 10 min-treatment 4 h-treatment + rIgG 1 13B8.2 + rIgG 1 13B8.2 + rIgG 1 13B8.2 73% 21% 50% 11% Events A 40 0 10 0 10 1 10 2 10 0 10 1 10 2 B 0 10 20 30 40 50 Ceramide-positive Jurkat T cells (%) Inhibitor - - FB1 FB1 ImiImi Myr Myr - + rIgG 1 13B8.2 + - - + - + Fig.3
description
Fig.3. A. 4 h-treatment. 10 min-treatment. 40. Non-permeabilized Jurkat T cells. + rIgG 1 13B8.2. 11%. + rIgG 1 13B8.2. Events. 10 2. 10 2. 10 1. 10 0. 10 1. 10 0. 21%. 0. Permeabilized Jurkat T cells. 40. + rIgG 1 13B8.2. + rIgG 1 13B8.2. 50%. Events. 73%. 10 2. - PowerPoint PPT Presentation
Transcript of + rIgG 1 13B8.2
+ rIgG1
13B8.2
100 101 102 100 101 102
Anti-ceramide antibody
Eve
nts
0
40
Non-permeabilizedJurkat T cells
PermeabilizedJurkat T cells
10 min-treatment 4 h-treatment
+ rIgG1
13B8.2
+ rIgG1
13B8.2+ rIgG1
13B8.273%
21%
50%
11%
Eve
nts
A40
0100 101 102100 101 102
B
0
10
20
30
40
50
Cer
amid
e-po
siti
veJu
rkat
T c
ells
(%
)
Inhibitor - - FB1 FB1 Imi Imi Myr Myr- +rIgG1 13B8.2 +- - + - +
Fig.3
